Along with some of the best companies in the world, Medable is proud to join CancerX as a founding member. This alliance is co-hosted by the Moffitt Cancer Center and the Digital Medicine Society (DiMe), alongside the Office for the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH).
Join us for our session in the innovation theater or stop by our booth to learn how digital offerings can improve patient experiences, see the…
Barbara Bierer (MRCT Center), Pam Tenaerts (Medable) and Leanne Madre (Medable) will present a framework, recommendations, and tools organized around 3 DCT domains: People, Remote…
Join us for our session in the innovation theater or stop by our booth to learn how digital offerings can improve patient experiences, see the…
DAY 1 – June 6, 2023 Closing the Acceptance Gap on Decentralised Clinical Trials 9am EST / 2pm BST / 3pm CEST Looking at the…
The recent release (May 2023) of the FDA’s Decentralized Clinical Trial (DCT) Draft Guidance has sparked a wave of excitement and anticipation within the field…
Despite years of effort, health data remains fragmented across institutions, sectors, and companies. There is no standardized way to collect or store non-individualized patient data;…
This Mother’s Day, women across the US and in other parts of the world will be celebrated, but this appreciation is not reflected in scientific…
The new FDA Patient Focused Drug Development (PFDD) Guidance Series and the Core Patient-Reported Outcomes Measures (PROMs) in Cancer Clinical Trials Guidance demonstrates the industry’s…
WEBINAR Sponsored by Medable, Inc. Thursday, May 11, 202311:00 AM -12:00 PM EDTLocation: Your office or conference room (no need to travel!) What’s the one…
